Back to today’s briefing

Story perspectives

Gene Therapies Offer Hope for 430 Million Hearing Loss Sufferers

3/4/2025

38 8

Summary

Story summary

More than 430 million people worldwide suffer from disabling hearing loss, according to the World Health Organization. In a bid to change lives, companies like Regeneron and Sensorion are pioneering gene therapies targeting specific conditions, such as otoferlin-related hearing loss. Exciting clinical trials are underway, showing hope for improved hearing in children through innovative treatments.

1 of 1

Story summary

More than 430 million people worldwide suffer from disabling hearing loss, according to the World Health Organization. In a bid to change lives, companies like Regeneron and Sensorion are pioneering gene therapies targeting specific conditions, such as otoferlin-related hearing loss. Exciting clinical trials are underway, showing hope for improved hearing in children through innovative treatments.